Skip to main content
. 2020 Aug 25;21(17):6133. doi: 10.3390/ijms21176133

Table 1.

Aminoglycoside susceptibility of E. coli aac(3)-IV.

E. coli Clinical aac(3)-IV Isolates E. coli Recombinant aac(3)-IV Strains
ATCC AG173 AG380 AG381 Promoter Strength
Aminoglycoside 25,922 WT + ++ +++
Apramycin 4 256–512 >512 >512 2 128 >512 >512
Gentamicin 0.5–1 8–16 32–64 64–128 0.25 8 64 128–256
Tobramycin 0.5–1 32 64–128 128 0.5 16 128–256 256–512
Amikacin 2 1 2–4 4 0.5–1 0.25–0.5 0.25 0.25–0.5
Sisomicin 0.5 8–16 16 32 0.125–0.25 2 16–32 128
Netilmicin 0.5 8–16 32–64 32 0.125–0.25 4–8 32–64 128
Plazomicin 0.5–1 0.5–1 1 1–2 0.25–0.5 0.125 0.125–0.25 0.125
Paromomycin 4 8 8 16 1 2 16 64–128